Clinical Trial Update: Terbinafine Compared to Griseofulvin in Children With Tinea Capitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing terbinafine to griseofulvin in children with tinea capitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Capitis

Drugs mentioned

• Griseofulvin (GRISEOFULVIN)
• Terbinafine (terbinafine)

Snippet

Sponsor: Novartis | Conditions: Tinea Capitis | Phase 3 | Status: COMPLETED